Bell2Bell’s latest podcast features Dr. Faz Chowdhury, Chairman and CEO of Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing and commercializing affordable diagnostic and digital tools for chronic disease management.

Throughout the interview, Chowdhury provided an introduction to Nemaura Medical and discussed its business model.

“Nemaura Medical was founded just over a decade back, and, over that period of time, we’ve been focused on developing a body-worn sensor designed for both consumer and medical applications in the diabetes space,” Chowdhury said. “We use the sensor to look at insight you otherwise could not gauge just by using existing technologies – taking a drop of blood and putting it on a strip, for example… It has taken us a good part of the 10 years to develop the technical aspects of the product, get the clinical studies done and get regulatory approvals in Europe. Now, we are already commercializing product in the UK, and we are looking at launching in other places in Europe and then into the U.S.”


Download(Loading)